SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services
FOR IMMEDIATE RELEASE Streamlined Organization Lays Foundation for Company Rebrand RANCHO CORDOVA, CA (December 11, 2024) — SK pharmteco, a...
Ensure Safety with Robust Replication-Competent Lentivirus (RCL) Assay: New White Paper
The safe application of lentiviral vectors in cell and gene therapy depends on precise risk mitigation strategies, particularly concerning replication-competent...
Viral vector integrity analysis – Advancements in gene therapy development
Gene therapy offers significant potential for addressing various genetic disorders. Over 30 gene therapies have received FDA approval, with more...
SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services
FOR IMMEDIATE RELEASE RANCHO CORDOVA, CA (December 11, 2024) — SK pharmteco, a global contract development, manufacturing, and analytical testing...
Advancing Viral Vector Manufacturing with Innovation: The Importance of the Cell Line
Join our experts for this on-demand 30-minute webinar to discuss the importance of cell lines in viral vector manufacturing, a...
Cell and Gene CDMO Services
SK pharmteco provides specialized solutions for Cell and Gene Therapy, encompassing viral vector manufacturing, plasmid DNA production, analytical testing, and...
Adapting a rcAAV Assay for Commercial Manufacturing
This white paper from SK pharmteco explores the development of a robust, GMP-compliant assay for detecting replication competent Adeno-Associated Virus...
Stability and Storage Testing
SK pharmteco offers comprehensive storage and stability testing services to support the quality and compliance of pharmaceutical products. With ICH-compliant...
SK pharmteco and AaviGen Announce Strategic Partnership to Manufacture AaviGen’s Lead Gene Therapy Product for Heart Failure
FOR IMMEDIATE RELEASE PARIS, France and HEIDELBERG, Germany (October 2, 2024) – SK pharmteco, a global contract development and manufacturing...